title: Metabolic imaging of rat brain during pharmacologically-induced tinnitus.
abstract: Although much is known about the perceptual characteristics of tinnitus, its neural origins remain poorly understood. We investigated the pattern of neural activation in central auditory structures using positron emission tomography (PET) imaging in a rat model of salicylate-induced tinnitus. Awake rats were injected with the metabolic tracer, fluorine-18 fluorodeoxyglucose (FDG), once in a quiet state (baseline) and once during salicylate-induced tinnitus. Tinnitus was verified using a behavioral technique. Brain imaging was performed using a high-resolution microPET scanner. Rats underwent magnetic resonance imaging (MRI) and reconstructed MRI and microPET images were fused to identify brain structures. FDG activity in brain regions of interest were quantified and compared. MicroPET imaging showed that FDG activity in the frontal pole was stable between baseline and tinnitus conditions, suggesting it was metabolically inert during tinnitus. Inferior colliculi (p=0.03) and temporal cortices (p=0.003) showed significantly increased FDG activity during tinnitus relative to baseline; activity in the colliculi and temporal cortices increased by 17%+/-21% and 29%+/-20%, respectively. FDG activity in the thalami also increased during tinnitus, but the increase did not reach statistical significance (p=0.07). Our results show increased metabolic activity consistent with neuronal activation in inferior colliculi and auditory cortices of rats during salicylate-induced tinnitus. These results are the first to show that microPET imaging can be used to identify central auditory structures involved in tinnitus and suggest that microPET imaging might be used to evaluate the therapeutic potential of drugs to treat tinnitus.
authors.affiliation: Department of Nuclear Medicine, State University of New York, University at Buffalo, Buffalo, NY 14214, USA. asit.paul@viahealth.org
authors.forename: A K
authors.initials: AK
authors.lastname: Paul
authors.forename: E
authors.initials: E
authors.lastname: Lobarinas
authors.forename: R
authors.initials: R
authors.lastname: Simmons
authors.forename: D
authors.initials: D
authors.lastname: Wack
authors.forename: John C
authors.initials: JC
authors.lastname: Luisi
authors.forename: J
authors.initials: J
authors.lastname: Spernyak
authors.forename: R
authors.initials: R
authors.lastname: Mazurchuk
authors.forename: H
authors.initials: H
authors.lastname: Abdel-Nabi
authors.forename: R
authors.initials: R
authors.lastname: Salvi
mesh_terms: D000818:Animals; D001921:Brain / Q000000981:diagnostic imaging* / Q000187:drug effects / Q000378:metabolism*; D004195:Disease Models, Animal; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D006801:Humans; D008297:Male; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D012980:Sodium Salicylate; D014012:Tinnitus / Q000139:chemically induced / Q000000981:diagnostic imaging* / Q000378:metabolism*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D012980:Sodium Salicylate